Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Innovent Announced 2022 Interim Results and Business Updates 2022-08-25 20:06
CStone Pharmaceuticals Reports 2022 Interim Results and Business Updates 2022-08-25 18:00
Everest Medicines Announces Interim Results for First Half of 2022 2022-08-24 21:10
Mangosteen Peel as Medicine - CU's Faculty of Veterinary Science is Successful in Replicating Mangosteen Peel Extract, Treatment for Intestinal Inflammation in Humans and Animals 2022-08-24 10:00
First US Patient Enrolled in SELUTION SLR IDE Peripheral Study 2022-08-24 09:00
Innovent Announces First Patient Dosing in Australia in Phase 1 Study of IBI363 (PD-1/IL-2 Bispecific Antibody Fusion Protein) in Patients with Advanced Malignancies 2022-08-24 08:00
Brii Biosciences Provides Corporate Update and Reports 2022 Interim Results 2022-08-24 07:30
Targeted Alpha Therapy Candidate: Bladder Cancer Study Completes Enrolment 2022-08-24 05:56
Zerion Pharma and Hovione extend partnership to cover use of the Dispersome® technology platform in nutraceuticals 2022-08-23 17:58
GenScript ProBio Congratulates Selecxine on FDA Clearance of IND Application for Innovative Antibody Drug Program 2022-08-23 14:15
Announcement of 2022 Future Science Prize Winners: Wenhui Li, Xueming Yang, Ngaiming Mok 2022-08-23 11:52
Brii Biosciences Appoints Eleanor de Groot as Chief Technology Officer and Aleksandar Skuban as Central Nervous System Diseases Therapy Area Head 2022-08-23 07:30
LTS takes next step in its Growth Journey with the acquisition of Tapemark Inc. 2022-08-22 18:00
The 2022 Smart China Expo kicked off, smart technology empowers Chongqing Liangjiang New Area to lead innovative development 2022-08-22 15:37
U.S. FDA Grants Emergency Use Authorization for Novavax COVID-19 Vaccine, Adjuvanted for Adolescents Aged 12 Through 17 2022-08-22 10:05
Sirnaomics Becoming A Constituent of Hang Seng Family of Indexes 2022-08-22 08:33
Ascletis Announces IND Approval of Oral RdRp Inhibitor ASC10 for COVID-19 by China NMPA 2022-08-22 08:10
Menarini Group's Elacestrant Marketing Authorization Application Accepted for Review by the European Medicines Agency (EMA) for the Treatment of ER+/HER2- Advanced or Metastatic Breast Cancer 2022-08-19 18:15
Sirnaomics Doses the First Patient in Phase I/II Clinical Study of RNAi Therapeutic STP705 for Treatment of Facial Squamous Cell Skin Cancer In Situ 2022-08-19 13:31
Completion Of Subject Enrollment And Vaccination For The Comparative Study Between ReCOV And mRNA Vaccines 2022-08-19 11:29
1 64 65 66 67 68 229